Literature DB >> 6866539

Naloxone fails to reverse pain thresholds elevated by acupuncture: acupuncture analgesia reconsidered.

Richard C Chapman1, Costantino Benedetti, Yoko H Colpitts, Rebecca Gerlach.   

Abstract

We were unable to demonstrate the reversal of dental acupunctural analgesia following the injection of 0.4 mg naloxone using evoked potential methodology. Since our findings differed from those of Mayer, Price and Rafii who used pain threshold methods, we attempted to replicate their study. Subjects who demonstrated acupunctural analgesia during electrical stimulation of the LI-4 point on the hands received either 1.2 mg naloxone or normal saline under double blind conditions. Pain thresholds elevated by acupuncture failed to reverse when naloxone was given. Review of experimental design issues, other related human subjects research, and animal studies on acupunctural analgesia provided little convincing evidence that endorphins play a significant role in acupunctural analgesia. Because endorphins can be released in response to a stressor, endorphin presence sometimes correlates with acupunctural treatment in animal studies and some human studies, especially those involving pain patients. The primary analgesia elicited by acupunctural stimulation seems to involve other mechanisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866539     DOI: 10.1016/0304-3959(83)90082-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  11 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Transcutaneous electrical nerve stimulation produces variable changes in somatosensory evoked potentials, sensory perception and pain threshold: clinical implications for pain relief.

Authors:  J F Golding; H Ashton; R Marsh; J W Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

3.  DoD-NCCAM/NIH workshop on acupuncture for treatment of acute pain.

Authors:  Emmeline Edwards; Jean Louis Belard; John Glowa; Partap Khalsa; Wendy Weber; Kristen Huntley
Journal:  J Altern Complement Med       Date:  2012-09-28       Impact factor: 2.579

4.  Auricular electrical stimulation and dental pain threshold.

Authors:  M S Simmons; T D Oleson
Journal:  Anesth Prog       Date:  1993

Review 5.  How effective is acupuncture for reducing pain due to plantar fasciitis?

Authors:  Anandan Gerard Thiagarajah
Journal:  Singapore Med J       Date:  2016-08-16       Impact factor: 1.858

6.  DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: roles of opioid and alpha2-adrenergic receptors.

Authors:  Yeong-Ray Wen; Chia-Chuan Wang; Geng-Chang Yeh; Sheng-Feng Hsu; Yung-Jen Huang; Yen-Li Li; Wei-Zen Sun
Journal:  J Biomed Sci       Date:  2010-03-19       Impact factor: 8.410

Review 7.  Mechanisms of acupuncture analgesia: effective therapy for musculoskeletal pain?

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

8.  Electroacupuncture-induced analgesia in a rat model of ankle sprain pain is mediated by spinal alpha-adrenoceptors.

Authors:  Sung Tae Koo; Kyu Sang Lim; Kyungsoon Chung; Hyunsu Ju; Jin Mo Chung
Journal:  Pain       Date:  2007-05-29       Impact factor: 6.961

9.  Involvement of spinal orexin A in the electroacupuncture analgesia in a rat model of post-laparotomy pain.

Authors:  Xiao-Ming Feng; Wen-Li Mi; Fang Xia; Qi-Liang Mao-Ying; Jian-Wei Jiang; Sheng Xiao; Zhi-Fu Wang; Yan-Qing Wang; Gen-Cheng Wu
Journal:  BMC Complement Altern Med       Date:  2012-11-22       Impact factor: 3.659

10.  Acupuncture treatment for plantar fasciitis: a randomized controlled trial with six months follow-up.

Authors:  Shi Ping Zhang; Tsui-Pik Yip; Qiu-Shi Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.